Combined imaging pinpoints those who would benefit from ICDs

08/12/2010 |

A Japanese study published in this month's Journal of Nuclear Medicine showed that using cardiac sympathetic nerve imaging with 123I-metaiodobenzylguanidine in combination with myocardial perfusion imaging helped determine which patients would need the implantation of a cardioverter defibrillator to deliver internal shocks. While there are still issues to be addressed in the study, the findings present "a rationale for further studies investigating the role of nuclear imaging for better selection of ICD candidates beyond left ventricular ejection measurements," the researchers said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC